In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

June 23, 2021
Judge Backtracks On Juror Vaccine Mandate In Opioid MDL

An Ohio federal judge said on Wednesday he wouldn't automatically throw out potential jurors in the national multidistrict opioid litigation because they are unvaccinated against COVID-19, undoing an earlier order requiring juror vaccinations.
June 22, 2021
Vaccine Mandate May Skew Opioid MDL Jury, Pharmacies Say

Limiting the pool of potential jurors to only those who have been fully vaccinated against COVID-19 could unfairly skew the jury in national multidistrict opioid litigation, pharmacies are telling an Ohio federal judge.
June 17, 2021
Walmart CEO Faces Opioid MDL Grilling Despite Protest

A special master in multidistrict opioid litigation has shot down Walmart's assertion that a requested deposition of its CEO is "harassing on its face," ruling that the grilling can go forward.
June 08, 2021
MSP Recovery's Opioid Claims Consolidated With Ohio MDL

The Judicial Panel on Multidistrict Litigation said Monday that MSP Recovery's opioid suit against CVS belongs in Ohio federal court as part of multidistrict litigation there, declining to vacate an order conditionally transferring the action.
June 07, 2021
JPML Sends McKinsey Opioid Cases To New MDL

The Judicial Panel on Multidistrict Litigation on Monday created a new MDL in California federal court for a barrage of lawsuits over McKinsey & Co.'s role in prescription opioid marketing, keeping the cases out of the existing opioid MDL in Ohio federal court.
June 04, 2021
Opioid Bellwether Trials Against Pharmacies To Be Bifurcated

The Ohio federal judge presiding over the opioid multidistrict litigation on Thursday split five upcoming bellwether trials against pharmacies into two phases, trying claims by local governments that the pharmacies created a public nuisance by overlooking suspicious orders first.
June 01, 2021
New Lead Atty In Opioid MDL Carries On 'Legacy' Of Hanly

A longtime partner of renowned trial lawyer Paul J. Hanly Jr., who died last month, took over Tuesday as a lead plaintiffs attorney in multidistrict opioid litigation and expressed optimism about progress with trials and settlement talks.
May 28, 2021
Key Opioid Trials To Watch As Cases Heat Up Nationwide

With the coronavirus crisis cooling down, a pressure cooker of opioid litigation is heating up with long-awaited trials across the country. Here, Law360 maps out the hottest cases and spotlights must-know details in trials that are underway or imminent.
May 27, 2021
JPML Weighs New Opioid MDL As McKinsey Suits Surge

New multidistrict litigation probably won't streamline dozens of cases accusing McKinsey & Co. of helping drugmakers aggressively market prescription opioids, but squeezing the cases into a long-running opioid MDL might be unfair, judges said Thursday.
May 21, 2021
Drugmakers Throw Purdue Under Bus In Opioid Trial Gamble

Major pharmaceutical companies embroiled in a multibillion-dollar opioid trial are pinning blame for rampant abuse of prescription narcotics on fellow drugmaker Purdue Pharma, gambling that they can impugn Purdue's marketing of OxyContin without incriminating their own promotion of painkillers.

← Previous
…
16
17
18
19
20
21
22
23
24
…
Next →